DISTRIBUTION AGREEMENT SIGNED COVERING SWITZERLANDDistribution Agreement • May 31st, 2021
Contract Type FiledMay 31st, 2021Amryt, a biopharmaceutical company focused on rare and orphan diseases, is pleased to announce that it has signed an exclusive distributor agreement for Lojuxta® (lomitapide) in Switzerland. The agreement is with RCC Pharma AG ("RCC"), a leading Swiss pharmaceutical company with expertise in early access programs in rare and orphan diseases.